Neurocrine Biosciences, Inc announced the launch of a new sprinkle formulation of INGREZZA capsules, the #1 prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the...
Exscientia plc announced that it has entered into an agreement to acquire GT Apeiron's interest in its oral CDK7 inhibitor program, thereby gaining full...
NMDP BioTherapies, a leader in cell and gene therapy development support, and the NMDP BioTherapies Cord Blood Bank Alliance (CBBA), a partnership between NMDP...
Galvani Bioelectronics, a clinical-stage therapeutics company formed through a strategic partnership between GSK and Verily Life Sciences to develop targeted neuromodulation therapies, announced it...
Sapio Sciences, the science-aware™ lab informatics platform, announced the Sapio Sciences Partner Program. The program provides a growing partner ecosystem of technology vendors, services companies,...
